Third Arc Bio
Operator of a biotech company intended to research multifunctional antibodies. The company's platform provides transformational therapies for solid tumors, inflammation, and immunology diseases in the...
Valuation
$315M
Latest known
Share Price
N/A
Total Raised
$197.7M
Last Round
N/A